naloxone hydrochloride
PolandDrugs containing this active substance
-
The medicine is used to counteract the effects of opioid overdose (e.g., morphine) in order to reverse their adverse effects, such as breathing difficulties or life-threatening respiratory and nervous system depression. It also helps in recognizing acute opioid poisoning or overdose.
Form: solution for injection or infusion in ampoule-syringe
Active substance Dosage naloxone hydrochloride 400 mcg/ml ATC: V03AB15
Manufacturer: Accord Healthcare Polska Ltd. Laboratori Fundació Dau
-
The medicine is used to reverse (block) the adverse effects of strong painkillers (opioids), such as drowsiness or breathing difficulties. It is used in cases of opioid overdose, to reverse their effects during surgery, to treat breathing difficulties in newborns, and to determine whether opioids are the cause of poisoning.
Form: solution for injection
Active substance Dosage naloxone hydrochloride 400 mcg/ml ATC: V03AB15
Manufacturer: Warsaw Pharmaceutical Works POLFA S.A.
-
The medicine is used to reverse (block) the adverse effects of strong painkillers (opioids), such as drowsiness or breathing difficulties. It is used in cases of opioid overdose, during recovery from anesthesia after surgery, to treat breathing difficulties in newborns, and to determine if opioids are the cause of poisoning.
Form: solution for injection
Active substance Dosage naloxone hydrochloride 400 mcg/ml ATC: V03AB15
Manufacturer: Warsaw Pharmaceutical Works POLFA S.A.
-
The medicine is used to reverse (block) the adverse effects of strong opioid painkillers, such as breathing difficulties or drowsiness. It is used in cases of opioid overdose, during recovery from surgical anesthesia, in the treatment of breathing difficulties in newborns, and to determine whether opioids are the cause of poisoning.
Form: solution for injection
Active substance Dosage naloxone hydrochloride 400 mcg/ml ATC: V03AB15
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
The medicine is used in adults to reduce the severity of severe pain that requires opioid treatment, and for the symptomatic treatment of severe restless legs syndrome in patients who cannot be treated with dopaminergic drugs.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 10 mg naloxone hydrochloride 5 mg ATC: N02AA55
Manufacturer: Develco Pharma GmbH, Saneca Pharmaceuticals a.s.
-
The medicine is used in adults to reduce the severity of severe pain that requires opioid treatment, and for the symptomatic treatment of severe restless legs syndrome in patients who cannot be treated with dopaminergic drugs.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 20 mg naloxone hydrochloride 10 mg ATC: N02AA55
Manufacturer: Develco Pharma GmbH, Saneca Pharmaceuticals a.s.
-
The medicine is used in adults to reduce the severity of severe pain that requires opioid treatment, and for the symptomatic treatment of severe restless legs syndrome in patients who cannot be treated with dopaminergic drugs.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 40 mg naloxone hydrochloride 20 mg ATC: N02AA55
Manufacturer: Develco Pharma GmbH, Saneca Pharmaceuticals a.s.
-
The medicine is used to treat severe pain that cannot be controlled by analgesics other than opioids.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 5 mg naloxone hydrochloride 2.5 mg ATC: N02AA55
Manufacturer: G.L. Pharma GmbH
-
The medicine is used to treat severe pain that can only be managed with opioid painkillers.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 10 mg naloxone hydrochloride 5 mg ATC: N02AA55
Manufacturer: G.L. Pharma GmbH
-
Oxylaxon is used to treat severe pain that can only be managed with opioid painkillers.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 20 mg naloxone hydrochloride 10 mg ATC: N02AA55
Manufacturer: G.L. Pharma GmbH
-
The medicine is used to treat severe pain that can only be controlled with opioid painkillers.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 30 mg naloxone hydrochloride 15 mg ATC: N02AA55
Manufacturer: G.L. Pharma GmbH
-
The medicine is used to treat severe pain that cannot be controlled by methods other than strong opioid painkillers.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 40 mg naloxone hydrochloride 20 mg ATC: N02AA55
Manufacturer: G.L. Pharma GmbH
-
The medicine is intended for the treatment of severe pain that can only be controlled with opioid medicines, and for the symptomatic second-line treatment of severe restless legs syndrome in adults.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 10 mg naloxone hydrochloride 5.00 mg ATC: N02AA55
Manufacturer: Fidelio Healthcare Limburg GmbH Mundipharma DC B.V.
-
The medicine is intended for the treatment of severe pain that cannot be controlled by other opioid medicines, and for the symptomatic second-line treatment of severe restless legs syndrome in adults.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 20 mg naloxone hydrochloride 10.00 mg ATC: N02AA55
Manufacturer: Fidelio Healthcare Limburg GmbH Mundipharma DC B.V.
-
It is used in the treatment of severe pain that requires opioid medication, and for the symptomatic second-line treatment of severe restless legs syndrome in adults.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 40 mg naloxone hydrochloride 20.00 mg ATC: N02AA55
Manufacturer: Fidelio Healthcare Limburg GmbH Mundipharma DC B.V.
-
The medicine is used in adults to treat severe pain that can only be controlled with opioid medicines, and for the symptomatic second-line treatment of severe restless legs syndrome.
Form: tablets, prolonged release
Active substance Dosage oxycodone hydrochloride 5 mg naloxone hydrochloride 2.50 mg ATC: N02AA55
Manufacturer: Fidelio Healthcare Limburg GmbH Mundipharma DC B.V.